Clinical Trials on Non-urothelial Bladder in Belgium
Total 879 results
-
Universiteit AntwerpenUnknownOveractive Bladder, Non Obstructive Urinary RetentionBelgium
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedUpper Tract Urothelial Carcinomas | Urothelial Bladder CancerUnited States, France, Canada, Spain, Italy, Belgium, Germany, Netherlands, United Kingdom, Bulgaria, Greece
-
Universiteit AntwerpenLeiden University Medical CenterUnknownOveractive Bladder | Non Obstructive Urinary RetentionBelgium
-
Association Pour La Recherche des Thérapeutiques...Roche Pharma AGCompletedRecurrent Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the BladderFrance, Belgium
-
Universiteit AntwerpenLeiden University Medical CenterUnknownOveractive Bladder | Non Obstructive Urinary RetentionBelgium
-
Universiteit AntwerpenUnknown
-
University Hospital, GhentCompletedMetastatic Urothelial CancerBelgium
-
VitadxFONDATION FORCE POUR L'INNOVATION ET LA RECHERCHE EN SANTERecruitingNon-muscle Invasive Bladder Cancer (NMIBC)France, Belgium, Spain
-
Jules Bordet InstituteMerck KGaA, Darmstadt, GermanyActive, not recruitingNon-metastatic Muscle Invasive Bladder CancerFrance, Belgium
-
ADC Therapeutics S.A.TerminatedBreast Cancer | Non Small Cell Lung Cancer | Bladder Cancer | GastroEsophageal CancerUnited States, Belgium
-
GlaxoSmithKlineCompletedNeoplasms, Urinary BladderBelgium
-
University Hospital, GhentCompleted
-
University Hospital, GhentTakedaCompleted
-
UNICANCERHoffmann-La RocheActive, not recruitingBladder CancerSpain, France, Belgium
-
Rainier TherapeuticsTerminatedUrinary Bladder Disease | Locally Advanced or Metastatic Urothelial Cell Carcinoma | Urological DiseasesUnited States, Spain, Belgium, France, Germany, Italy, Korea, Republic of, Turkey, Hungary, Netherlands, Serbia, Poland, Russian Federation, Sweden, Moldova, Republic of, Denmark, Ukraine
-
AstraZenecaActive, not recruitingNon-muscle-invasive Bladder CancerFrance, Spain, Belgium, Canada, Poland, Germany, Japan, Russian Federation, United Kingdom, Austria, Australia, Netherlands
-
University Hospital, GhentKom Op Tegen KankerRecruitingMuscle-Invasive Bladder CarcinomaBelgium
-
University Hospital, GhentAstellas Pharma Inc; MedtronicCompleted
-
University Hospital, GhentTerminatedOveractive Bladder SyndromeBelgium
-
University Hospital, GhentCompletedSurgery | Bladder Cancer | Urologic CancerBelgium
-
AstraZenecaCompletedPancreatic Ductal Adenocarcinoma | Triple-negative Breast Cancer | Urothelial Bladder CancerUnited States, Belgium, Korea, Republic of, Poland, Netherlands
-
KU LeuvenAgentschap voor Innovatie door Wetenschap en TechnologieCompletedBladder CancerBelgium
-
Jules Bordet InstituteEli Lilly and CompanyCompletedCholangiocarcinoma | Endometrial Cancer | Esophageal Adenocarcinoma | Urothelial/Bladder Cancer, Nos | Esophagus SCCFrance, Belgium
-
University Hospital, GhentMedtronicCompletedUrinary Retention | Fecal Incontinence | Overactive Bladder Syndrome | Dysfunctional Voiding | Fowler SyndromeBelgium
-
University Hospital, GhentActive, not recruiting
-
Merck Sharp & Dohme LLCRecruitingHigh-risk Non-muscle Invasive Bladder CancerCanada, Belgium, United States, Australia, Austria, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Poland, Portugal, Spain, Switzerland, Turkey, United Kingdom, China, Brazil, Colombia, ... and more
-
Jessa HospitalCompletedBladder Cancer | Antibiotic-associated Diarrhea | Antibiotic Resistant Infection | Antibiotic Resistant Strain | Antibiotic Toxicity | Prostate Hyperplasia | UrosepsisBelgium
-
Amphora Medical, Inc.Terminated
-
Amber Therapeutics LtdActive, not recruiting
-
National Multiple Sclerosis CenterTerminatedInterstitial Cystitis | Painful Bladder SyndromeBelgium
-
Janssen Research & Development, LLCRecruitingBladder CancerUnited States, Belgium, Korea, Republic of, Italy, Taiwan, China, United Kingdom, Germany, France, Argentina, Brazil, Poland, Spain, Czechia, Japan, Netherlands, India, Canada, Mexico, Australia, Portugal
-
PfizerActive, not recruitingNon-muscle Invasive Bladder CancerChina, United States, Spain, Belgium, Korea, Republic of, Australia, United Kingdom, Japan, France, Germany, Canada, Russian Federation, Poland, Italy
-
Janssen Research & Development, LLCRecruitingUrinary Bladder NeoplasmsUnited States, Belgium, Korea, Republic of, Germany, Italy, France, Spain, Canada, United Kingdom, Greece, Japan, Netherlands, Portugal, Australia, Russian Federation, Ukraine
-
University Hospital, GhentAlgemeen Ziekenhuis Maria Middelares; AZ Sint-Lucas Gent; AZ Jan Palfijn GentNot yet recruitingOveractive Bladder | Sacral Neuromodulation | Diversity | Onabotulinum Toxin A | Discrete Choice ExperimentBelgium
-
Axonics Modulation Technologies, Inc.CompletedOveractive BladderNetherlands, France, Belgium, United Kingdom
-
Universiteit AntwerpenRecruitingOveractive Bladder | Voiding Disorders | Pelvic Organ Prolapse | Stress Urinary Incontinence | Urge IncontinenceBelgium
-
PfizerCompletedNeurogenic Detrusor OveractivityBelgium
-
Janssen Research & Development, LLCActive, not recruitingUrinary Bladder NeoplasmsUnited States, Japan, China, Korea, Republic of, France, Belgium, Czechia, Taiwan, Italy, Poland, United Kingdom, Spain, Germany, Australia, Brazil, Argentina, India
-
Astellas Pharma Europe B.V.Veeda Clinical ResearchCompletedLower Urinary Tract Predominant Storage SymptomsBelgium
-
University of ZurichRecruitingNeurogenic Bladder DysfunctionBelgium, Brazil, Italy, Switzerland
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenRecruiting
-
Janssen Research & Development, LLCRecruitingUrinary Bladder NeoplasmsUnited States, Korea, Republic of, France, Israel, Spain, Italy, United Kingdom, Belgium, Netherlands, Germany
-
Incyte CorporationTerminatedMetastatic Urothelial Carcinoma | Unresectable Urothelial CarcinomaSpain, France, United States, Italy, Japan, Ireland, Slovakia, Austria, Belgium, Canada, Finland, Germany, Poland, Portugal, Romania, United Kingdom
-
AstraZenecaActive, not recruitingUrothelial CancerUnited States, Belgium, Denmark, Germany, Italy, Spain, Canada, Poland, Taiwan, France, Korea, Republic of, Netherlands, United Kingdom, Brazil, Japan, Mexico, Russian Federation, Turkey, China, Austria, Australia, Israel, Portugal, G...
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.RecruitingUrothelial CancerUnited States, Argentina, Australia, Belgium, Canada, China, Czechia, Denmark, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Singapore, Spain, Switzerland, Taiwan, Thailand and more
-
PfizerCompletedNeurogenic Detrusor OveractivityBelgium
-
European Organisation for Research and Treatment...TerminatedBladder CancerNetherlands, Belgium, Italy, Turkey, Slovakia
-
Astellas Pharma IncCompletedOveractive Bladder | Neurogenic Detrusor OveractivityBelgium, Canada, Denmark, Netherlands, Poland, Turkey, United Kingdom
-
University of LiegeFondation BenoitWithdrawnNon-Metastatic NeoplasmBelgium
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CancerUnited States, France, Germany, United Kingdom, Belgium, Taiwan, Spain, Israel, India, Romania, Korea, Republic of, Russian Federation, Turkey, Austria, Moldova, Republic of